<DOC>
	<DOCNO>NCT01330823</DOCNO>
	<brief_summary>The study investigate role L-Carnitine supplementation proinflammatory immune response , malnutrition , cancer cachexia cancer relate fatigue advance inoperable pancreatic cancer , UICC Stage IV .</brief_summary>
	<brief_title>L-CARnitine Palliative Treatment Advanced PANcreatic Cancer ( CARPAN )</brief_title>
	<detailed_description>Pancreatic cancer low 5-year survival rate cancer rank fourth lead cause cancer death world wide . Several metabolic change present whole body case cancer investigator conduct placebo control , double blind , randomize , prospective multicentre study investigate , whether L-Carnitine supplementation may impact malnutrition , cancer cachexia cancer relate fatigue advance pancreatic cancer . Study drug : L-Carnitine 4g per day ( vers ) Placebo Study design : A multi-centre , double blind , placebo-controlled , randomise , parallel group study Patient population : Patients advance pancreatic carcinoma Number patient : Total 90 patient two equal group number centre : 4 ( Greifswald , Magdeburg , Berlin , Heidelberg , Germany ) Duration dosing : 12 week</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>advanced pancreatic cancer ( UICC Stage IV ) Karnofsky Index large 60 compliance consent participate study ChildPugh classification liver failure great Child B , know second malignant tumor oral parenteral supplementation omega3fatty acid treatment thalidomide Infliximab mental physical disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>pancreatic carcinoma</keyword>
	<keyword>L-Carnitine</keyword>
	<keyword>quality life</keyword>
	<keyword>survival</keyword>
	<keyword>malnutrition</keyword>
	<keyword>cancer cachexia</keyword>
	<keyword>fatigue</keyword>
</DOC>